Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$16.7 - $21.63 $136,505 - $176,803
8,174 New
8,174 $172,000
Q2 2022

Aug 15, 2022

SELL
$15.73 - $22.91 $238,812 - $347,819
-15,182 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$16.95 - $21.74 $257,334 - $330,056
15,182 New
15,182 $325,000
Q3 2021

Nov 15, 2021

SELL
$22.29 - $28.7 $887,208 - $1.14 Million
-39,803 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$22.32 - $32.07 $888,402 - $1.28 Million
39,803 New
39,803 $1.13 Million
Q4 2020

Feb 16, 2021

SELL
$16.76 - $23.74 $1.2 Million - $1.7 Million
-71,788 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$16.35 - $21.4 $955,281 - $1.25 Million
58,427 Added 437.3%
71,788 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$16.34 - $25.24 $218,318 - $337,231
13,361 New
13,361 $256,000
Q1 2020

May 15, 2020

SELL
$14.66 - $30.57 $435,900 - $908,968
-29,734 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$22.45 - $27.09 $667,528 - $805,494
29,734 New
29,734 $805,000
Q3 2019

Nov 14, 2019

SELL
$25.98 - $30.8 $475,797 - $564,071
-18,314 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$27.55 - $32.39 $504,550 - $593,190
18,314 New
18,314 $548,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.25B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.